2019/05/31 by Michael D. Chuong, Adeel Kaiser, Fazal Hameed Khan +19 · 1 citation
Medicine · #Hepatocellular Carcinoma Treatment and Prognosis #Hepatitis B Virus Studies #Radiation Therapy and Dosimetry
paper · pdf · doi:10.3389/fonc.2019.00457
openalex publication_date 2019/05/31 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04
An international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed.